The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Recruiting N/A Interventional Study
Hip Osteoarthritis Muscle Weakness Muscle Atrophy Muscle Injury Arthroplasty Complications
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
580 (estimated)
Sponsor
Sahlgrenska University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Primary unilateral osteoarthritis of the hip scheduled for total hip arthroplasty. * Ability to understand and write swedish. Exclusion Criteria: * Impaired funktion of the contralateral hip or knees causing limping. * Neuromuscular diseases * Postoperative leg length discre…
Contacts

Georgios Tsikandylakis, MD PhD

0046313421000

tsikandylakis@gmail.com

CONTACT